Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Preconference

Emerging New Therapeutic Modalities

Model-Informed Drug Development Applications to Oncology Bispecifics and Antibody-Drug Conjugates

Sunday, November 10, 2024
2:10 PM – 2:35 PM MST
Location: Sonoran Sky Ballroom 4

    Speaker(s)

  • DY

    Donghua Yin, PhD

    Vice President, Head of Clinical Pharmacology, Pfizer Oncology Division
    Pfizer, California, United States

    Disclosure(s): Pfizer Inc: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Disclosure(s):
Donghua Yin, PhD: Pfizer Inc: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Back to Top